Financials

  • Market Capitalization 292.21 M
  • Employee 28
  • Founded 2018
  • CEO N/A
  • Website www.opusgtx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BT34Q3
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.51
Price to sales ratio
8.81

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3356
NMRA
Neumora Therapeutics, Inc. - Common Stock
1.60 USD0.00%-13.04%+72.04%+24.03%296.45 M USD
3361
INDP
Indaptus Therapeutics, Inc. - Common Stock
2.60 USD-1.14%-6.14%-28.18%+36.84%294.43 M USD
3388
TTRX
Turn Therapeutics Inc. - Common Stock
9.52 USD+0.53%+9.80%+54.05%-4.80%283.58 M USD
3389
MGNX
MacroGenics, Inc. - Common Stock
4.45 USD-1.11%-5.12%+12.37%+183.44%282.86 M USD

Frequently asked questions about Opus Genetics, Inc. - Common Stock

What is the Opus Genetics, Inc. - Common Stock stock price today?

The current price of Opus Genetics, Inc. - Common Stock (IRD) is 3.59. Over the past 24 hours, the stock has changed by -5.77%. Follow the IRD chart for real-time price dynamics.

What is the stock ticker of Opus Genetics, Inc. - Common Stock?

Opus Genetics, Inc. - Common Stock trades under the ticker IRD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Opus Genetics, Inc. - Common Stock stock going up?

IRD has changed by -12.65% over the last week, -12.86% over the last month, and -3.49% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Opus Genetics, Inc. - Common Stock net income for the last quarter?

Opus Genetics, Inc. - Common Stock reported net income of -65.53 M for the last quarter. The previous quarter showed -16.52 M, which means net income changed by -296.63%.

How many employees does Opus Genetics, Inc. - Common Stock have?

As of the latest available data, Opus Genetics, Inc. - Common Stock has 28 employees. Workforce size can provide additional context about the company's scale and operations.

What is Opus Genetics, Inc. - Common Stock EBITDA?

Opus Genetics, Inc. - Common Stock EBITDA is -14.35 M, and its EBITDA margin is -665.32%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Opus Genetics, Inc. - Common Stock stock?

You can buy Opus Genetics, Inc. - Common Stock (IRD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Opus Genetics, Inc. - Common Stock stock?

Investing in Opus Genetics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IRD chart and related analysis on metatrader.com as part of your research.